drugdeliverybusiness1d
Embecta discontinues insulin patch pump program, plans restructuring
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
drugdeliverybusiness8d
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.
drugdeliverybusiness7d
Medtronic wins FDA nod for new InPen app to support launch with Simplera CGM
Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.
drugdeliverybusiness7d
Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus in the U.S.
Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...
drugdeliverybusiness13d
Beta Bionics raises $60M Series E to support iLet bionic pancreas
Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.
drugdeliverybusiness7d
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.
drugdeliverybusiness13d
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
drugdeliverybusiness8d
Medtronic to submit MiniMed 780G to FDA for type 2 diabetes in 2025, updates on patch pump
Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.